In June, Gilead was freed from paying up $200 million in damages for infringing two Merck patents related to Gilead's blockbuster drugs Sovaldi and Harvoni, after a U.S. judge found a pattern of misconduct by Merck including lying under oath and other unethical practices.
六月，在美国法官发现默克公司存在违法行为，包括作伪证和其他不道德行为之后，吉列德免于支付因吉利德的畅销药品索非布韦和哈沃尼侵犯默克公司的两项专利而产生的2亿美元赔偿款。